Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Mike Crawley, CEO of Northland Power, joins BNN Bloomberg to discuss recent company updates, developments, and upcoming projects.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Mike Crawley. President/CEO, Northland Power Inc ;
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Tribeca Investment Partners' Guy Keller on Nuclear Energy Opportunities Fund Performance and Uranium Market Insights
00:00:00
Battling Drug Resistance - Maha Farhat, MD, MSc Gilbert S. Omenn Associate Professor of Biomedical Informatics, HMS
00:10:00
How Kovac Provides Unmatched Support and Freedom for Financial Advisors
00:10:00
Beijing Enterprises generates its main revenue from 100% owned Beijing Gas and 44% owned Beijing Enterprises, specializing in water and solid waste treatment.
00:10:00
Artemis Resources: Advancing Carlo Castle Gold-Copper-Cobalt Project with Radio Hill Processing Plant
00:10:00
"Mastering Investment Decisions in 2024: Insights with Caspar Berry | Schroders Investor Download Podcast"
00:10:00
Crone PEM Damping Box Data Transfer Guide | Dave Campbell, Director of Crone Geophysics & Exploration Ltd.
00:10:00
Cerrado Gold: Driving Growth with Strategic Projects in South America
00:10:00
Clay McCreary from Vessel Discusses True Live, a Game-Changing Solution at NAB Show Live | Clay McCreery, Chief Operating Officer at Vecima Networks Inc.
00:10:00
Advancing Business Process Optimization through Process Mining and AI Integration
00:10:00
Energy Transition Minerals Updates on Greenland Dispute and Lithium Exploration in Spain
00:10:00
Precious Metals Outlook: Dynamics and Risks in PGM Markets